U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a new federal initiative to build a comprehensive autism data platform using Medicare and Medicaid records. Designed to study the causes of autism spectrum disorder (ASD), the platform will integrate claims data, electronic health records, and data from wearable health devices, according to the Department of Health and Human Services (HHS).
The National Institutes of Health (NIH) and the Centers for Medicare and Medicaid Services (CMS) will collaborate on the effort, which is part of a broader $50 million research initiative to investigate potential environmental and medical causes of autism. Kennedy stated the project aims to provide "honest answers families have waited far too long to hear," despite his controversial history promoting a debunked link between vaccines and autism.
HHS said the platform will help researchers analyze autism diagnoses, treatment outcomes, healthcare access disparities, and the financial impact on families. However, experts like Dr. Helen Tager-Flusberg of Boston University argue the focus does not directly address autism’s root causes. She also noted that an existing NIH autism database recently went offline without explanation, raising concerns about transparency.
The project has sparked privacy questions, as HHS has not confirmed whether the database will be anonymous or voluntary. Autism researcher Eric Rubenstein noted that Medicaid and Medicare data offer insights into health disparities but lack environmental exposure data, which Kennedy claims he will explore.
Autism rates have surged in recent years, with the CDC reporting 1 in 31 U.S. 8-year-olds diagnosed in 2022. While Kennedy aims to identify autism’s causes by September, scientists emphasize that autism likely stems from a complex mix of genetic and environmental factors. Critics warn against oversimplifying this ongoing scientific challenge.


U.S. Budget Airlines Seek $2.5 Billion Government Aid Amid Rising Jet Fuel Costs
Panama Defends Port Takeover Amid U.S.-China Tensions and Canal Dispute
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
U.S. Flags Vietnam as “Priority Foreign Country” Over Intellectual Property Concerns
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
Judge Delays SEC Settlement With Elon Musk Over Twitter Stock Disclosure Case
Dominican Republic Halts GoldQuest Mining Project Amid Environmental Protests
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Federal and State Authorities Conduct Widespread Fraud Raids Across Minnesota
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
Ghana Rejects U.S. Health Deal Over Data Sharing Concerns Amid Foreign Aid Shift
Trump Expands Cuba Sanctions Targeting Key Sectors and Foreign Entities 



